Click on a filter below to refine your search. Remove a filter to broaden your search.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Some of the factors include social isolation, diabetes, heart disease, vitamin D deficiency, high C-reactive protein and low handgrip strength.
The findings persisted across age, sex and comorbidities.